Johnson & Johnson (NYSE:JNJ) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. JNJ Delivers Strong 2026 Guidance Even as Policy Costs Loom Johnson & Johnson (NYSE:JNJ) posted its fourth-quarter 2025 earnings on January 21 and followed it up with a 2026 outlook that came in ahead of Wall Street expectations. What stood out is that the guidance still looks strong even with a couple of big headwinds hanging over the business, such as a drug pricing deal with the Trump administration and ...